SanjeevSethi United StatesMayo Clinic

SanjeevSethi
Dr. Sanjeev Sethi graduated from Assam Medical College, India (MBBS, 1985) and completed his pathology residency at Sarojini Naidu Medical College (MD, 1989). He pursued graduate studies thereafter at Albany Medical College, NY, and received his Ph.D. in Experimental Pathology (1991-1995). His PhD work was awarded the Dean’s certificate and the Leonard Procita award for the Most Outstanding Research. Subsequently, Dr. Sethi completed his Pathology residency at Yale University (1995-1999) and his fellowship in Renal Pathology at Brigham and Women’s Hospital, Harvard University (1999-2001). He is currently a Professor at Mayo Clinic, Rochester. His primary interests and research are in 1) Glomerulonephritis, with a focus on an etiologic approach to glomerulonephritis, the role of monoclonal gammopathy in glomerulonephritis, and the role alternative pathway of complement in glomerulonephritis, 2) Application of proteomics in renal pathology. New diseases and pathways have been identified using this novel approach. These include identification of new types of amyloidosis, novel antigens in membranous nephropathy, and complement pathways in glomerular diseases. These studies have resulted in over 275 peer-reviewed publications. He has also led consensus studies for classification of glomerulonephritis, monoclonal immunoglobulin-associated kidney diseases, membranous nephropathy and standardization of reporting and chronicity scoring of the kidney biopsy. Dr. Sethi is sought after speaker and has given over 200 invited lectures both nationally and internationally. For his contributions to renal pathology and clinical service, Dr. Sethi was awarded the Jacob Churg Award 2020 by the Renal Pathology Society and the Distinguished Clinician Award 2021 by Mayo Clinic, and the invited Pirani lectureship by Columbia University in 2022.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/a775ceaa1e60d2d0bdd6308da1fa2a20.jpg
First Name
Sanjeev
Last Name
Sethi
Institution
Country.
United States

Saturday, February 8, 2025

Time Session
2:15 p.m.
3:45 p.m.
SK2002
RajkumarSharma Chair IndiaDirector and Head of Department of Nephrology, Medanta Hospital, Lucknow
Swetha RaniKanduri Chair United StatesOchsner Health, New Orleans, LA
  • Evaluating Kidney Allograft Dysfunction
    SK2002-001
    SumitMohan Speaker United StatesColumbia University
  • Advances in Glomerular Disease Treatment
    SK2002-02
    JonathanBarratt Speaker United KingdomUniversity of Leicester, Leicester, UK
  • Risk Prediction in AKI and CKD
    SK2002-03
    NavdeepTangri Speaker CanadaUniversity of Manitoba, SOGH Chronic Disease Innovation Centre
  • Prioritizing Patient-friendly Dialysis
    SK2002-04
    EdwinaBrown Speaker United KingdomImperial College Healthcare NHS Trust
  • Glomerular Disease Diagnostics
    SK2002-01
    SanjeevSethi Speaker United StatesMayo Clinic
  • Q&A
    SK2002-06
Brahmkamal Hall - Plenary Hall

Thursday, February 6, 2025

Time Session
11:30 a.m.
1:30 p.m.
PATH2
CarmenAvila Casado Chair CanadaUniversity of Toronto, UHN
GeetikaSingh Chair IndiaAll India Institute of Medical Sciences, New Delhi, India
SuryaSeshan Chair United StatesWeill Cornell Medicine
  • Mass Spectrometry for the Diagnosis of Renal Diseases
    PATH2-1
    SanjeevSethi Speaker United StatesMayo Clinic
  • Application of Digital Tools in Renal Pathology
    PATH2-2
    ArvydasLaurinavicius Speaker LithuaniaVilnius University
  • The Importance of Medullary Lesions In Kidney Biopsies
    PATH2-3
    JorisRoelofs Speaker NetherlandsAmsterdam UMC
  • New Insights in Drug Induced Kidney Diseases
    PATH2-4
    SuryaSeshan Speaker United StatesWeill Cornell Medicine
  • Q and A
    PATH2-5
Amaltas Hall B101-B